To the best of our knowledge, our present study is the first to investigate in depth the involvement of FREM2 and SPRY1 in glioblastomas at different molecular levels using human samples, as well as using advanced in-silico approaches to enlarge the sample size. This evidence concerns the gene SPRY1 and glioblastoma.